OLIG2 and glioblastoma: Furthermore, the presence of PolySia-NCAM has been identified as a negative predictor for prognosis in GBM and has been demonstrated to regulate oligodendrocyte transcription factor (OLIG2), a key factor oligodendrocyte differentiation involved in the tumor initiation, proliferation, and phenotypic plasticity [27,63,64].